“Long-term Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study”, J of Skin, vol. 4, no. 6, p. s87, Oct. 2020, doi: 10.25251/skin.4.supp.87.